OBSOLETE: Gastric neuroendocrine tumor type 4

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:481481
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Gastric neuroendocrine tumor type 4 (also sometimes called type 4 gastric NET or sporadic gastric carcinoid type 4) is a rare and aggressive form of stomach tumor that starts in the hormone-producing cells of the stomach lining. Unlike the other three types of gastric neuroendocrine tumors, type 4 does not develop because of high levels of a hormone called gastrin. Instead, it arises on its own, without a clear hormonal trigger, and tends to behave more like a typical stomach cancer. It is worth noting that this classification has been marked as 'obsolete' in some medical databases, meaning experts have updated how they categorize and name these tumors over time. You may see it referred to under newer classification systems for gastric neuroendocrine neoplasms. This type of tumor can grow quickly and spread to other parts of the body, including nearby lymph nodes and the liver. Because it often does not cause obvious symptoms early on, it is frequently found at an advanced stage. Symptoms can include stomach pain, nausea, weight loss, and bleeding in the digestive tract. Treatment usually involves surgery when possible, along with chemotherapy or targeted therapies. The overall outlook depends heavily on how far the tumor has spread at the time of diagnosis, and early detection greatly improves the chances of successful treatment.

Also known as:

Key symptoms:

Stomach pain or discomfortNausea and vomitingUnintended weight lossLoss of appetiteFeeling full quickly after eatingBlood in the stool or black, tarry stoolsFatigue and weaknessAnemia (low red blood cell count)Swelling in the abdomenJaundice (yellowing of the skin or eyes) if the liver is affected

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Gastric neuroendocrine tumor type 4.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Gastric neuroendocrine tumor type 4 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Gastric neuroendocrine tumor type 4 community →

No specialists are currently listed for OBSOLETE: Gastric neuroendocrine tumor type 4.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Gastric neuroendocrine tumor type 4.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Gastric neuroendocrine tumor type 4Forum →

No community posts yet. Be the first to share your experience with OBSOLETE: Gastric neuroendocrine tumor type 4.

Start the conversation →

Latest news about OBSOLETE: Gastric neuroendocrine tumor type 4

No recent news articles for OBSOLETE: Gastric neuroendocrine tumor type 4.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my tumor, and has it spread to other organs?,What treatment options are available for my specific situation, and what are the goals of treatment?,Am I a candidate for surgery, and what would that involve?,Are there any clinical trials I might be eligible for?,What imaging and blood tests will I need for ongoing monitoring, and how often?,Should I be seen at a specialized neuroendocrine tumor center?,What support services are available to help me and my family cope with this diagnosis?

Common questions about OBSOLETE: Gastric neuroendocrine tumor type 4

What is OBSOLETE: Gastric neuroendocrine tumor type 4?

Gastric neuroendocrine tumor type 4 (also sometimes called type 4 gastric NET or sporadic gastric carcinoid type 4) is a rare and aggressive form of stomach tumor that starts in the hormone-producing cells of the stomach lining. Unlike the other three types of gastric neuroendocrine tumors, type 4 does not develop because of high levels of a hormone called gastrin. Instead, it arises on its own, without a clear hormonal trigger, and tends to behave more like a typical stomach cancer. It is worth noting that this classification has been marked as 'obsolete' in some medical databases, meaning ex

How is OBSOLETE: Gastric neuroendocrine tumor type 4 inherited?

OBSOLETE: Gastric neuroendocrine tumor type 4 follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Gastric neuroendocrine tumor type 4 typically begin?

Typical onset of OBSOLETE: Gastric neuroendocrine tumor type 4 is adult. Age of onset can vary across affected individuals.